Leonard A. Levin

7.1k total citations
154 papers, 4.8k citations indexed

About

Leonard A. Levin is a scholar working on Ophthalmology, Molecular Biology and Neurology. According to data from OpenAlex, Leonard A. Levin has authored 154 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Ophthalmology, 65 papers in Molecular Biology and 28 papers in Neurology. Recurrent topics in Leonard A. Levin's work include Glaucoma and retinal disorders (56 papers), Retinal Development and Disorders (36 papers) and Traumatic Brain Injury and Neurovascular Disturbances (20 papers). Leonard A. Levin is often cited by papers focused on Glaucoma and retinal disorders (56 papers), Retinal Development and Disorders (36 papers) and Traumatic Brain Injury and Neurovascular Disturbances (20 papers). Leonard A. Levin collaborates with scholars based in United States, Canada and New Zealand. Leonard A. Levin's co-authors include Christopher J. Lieven, Helen V. Danesh‐Meyer, Michael P. Joseph, Mohammadali Almasieh, Maria‐Magdalena Catrinescu, Raymond T. Kraker, Stuart R. Seiff, Roy W. Beck, Christopher R. Schlieve and Jeffrey M. Liebmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Nature Medicine.

In The Last Decade

Leonard A. Levin

151 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonard A. Levin United States 40 2.7k 1.9k 835 779 747 154 4.8k
Patrick Yu‐Wai‐Man United Kingdom 41 1.5k 0.5× 5.4k 2.8× 210 0.3× 543 0.7× 247 0.3× 145 6.4k
Joshua L. Dunaief United States 45 2.7k 1.0× 3.6k 1.9× 131 0.2× 233 0.3× 1.1k 1.5× 146 6.9k
Noemi Lois United Kingdom 46 4.9k 1.8× 2.1k 1.1× 170 0.2× 507 0.7× 3.0k 4.0× 150 6.4k
Przemysław Sapieha Canada 43 2.3k 0.8× 3.0k 1.6× 195 0.2× 127 0.2× 1.5k 2.1× 96 5.8k
Florian Sennlaub France 45 3.1k 1.2× 2.5k 1.3× 195 0.2× 133 0.2× 1.5k 2.0× 127 6.1k
Neeraj Agarwal United States 40 1.1k 0.4× 3.6k 1.9× 463 0.6× 87 0.1× 315 0.4× 118 5.2k
Toshihide Kurihara Japan 39 3.0k 1.1× 2.3k 1.2× 155 0.2× 112 0.1× 1.8k 2.5× 193 5.5k
Massimo Dal Monte Italy 35 1.0k 0.4× 1.4k 0.7× 142 0.2× 103 0.1× 751 1.0× 131 3.3k
Pierre Hardy Canada 37 862 0.3× 1.5k 0.8× 194 0.2× 162 0.2× 842 1.1× 111 3.8k

Countries citing papers authored by Leonard A. Levin

Since Specialization
Citations

This map shows the geographic impact of Leonard A. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard A. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard A. Levin more than expected).

Fields of papers citing papers by Leonard A. Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard A. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard A. Levin. The network helps show where Leonard A. Levin may publish in the future.

Co-authorship network of co-authors of Leonard A. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard A. Levin. A scholar is included among the top collaborators of Leonard A. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard A. Levin. Leonard A. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levin, Leonard A., et al.. (2025). A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy. Ophthalmology. 133(1). 62–74. 2 indexed citations
2.
Glassman, Adam R., Darrell E. Baskin, Mitchell Brigell, et al.. (2024). Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available Measures. Ophthalmology Science. 4(5). 100519–100519. 13 indexed citations
3.
Yang, Fan, Mohammadali Almasieh, & Leonard A. Levin. (2024). In Vivo Imaging of Secondary Neurodegeneration Associated With Phosphatidylserine Externalization Along Axotomized Axons. Investigative Ophthalmology & Visual Science. 65(2). 24–24.
4.
Levin, Leonard A., Michael F. Chiang, Michael A. Dyer, et al.. (2023). Translational roadmap for regenerative therapies of eye disease. Med. 4(9). 583–590. 1 indexed citations
5.
Levin, Leonard A., et al.. (2023). Redox Targets for Phosphine–Boranes. Inorganics. 11(7). 310–310. 1 indexed citations
6.
Gelder, Russell N. Van, Michael F. Chiang, Michael A. Dyer, et al.. (2022). Regenerative and restorative medicine for eye disease. Nature Medicine. 28(6). 1149–1156. 68 indexed citations
7.
Farrokhyar, Forough, et al.. (2022). Equity, diversity, and inclusion landscape in Canadian postgraduate medical education for ophthalmology. Canadian Journal of Ophthalmology. 59(1). 31–39. 2 indexed citations
8.
Levin, Leonard A., et al.. (2022). Increasing equity, diversity, and inclusion in the ophthalmology CaRMS selection process: ACUPO recommendations. Canadian Journal of Ophthalmology. 58(2). e58–e60. 1 indexed citations
10.
Almasieh, Mohammadali, et al.. (2021). Axonal degeneration induces distinct patterns of phosphatidylserine and phosphatidylethanolamine externalization. Cell Death Discovery. 7(1). 247–247. 10 indexed citations
11.
Coussa, Razek Georges, et al.. (2019). Propagation and Selectivity of Axonal Loss in Leber Hereditary Optic Neuropathy. Scientific Reports. 9(1). 6720–6720. 11 indexed citations
12.
Lieven, Christopher J., et al.. (2017). Polyester-based microdisc systems for sustained release of neuroprotective phosphine-borane complexes. Pharmaceutical Development and Technology. 23(9). 882–889. 2 indexed citations
13.
Lawlor, Mitchell, Helen V. Danesh‐Meyer, Leonard A. Levin, et al.. (2017). Glaucoma and the brain: Trans-synaptic degeneration, structural change, and implications for neuroprotection. Survey of Ophthalmology. 63(3). 296–306. 86 indexed citations
14.
Almasieh, Mohammadali, Maria‐Magdalena Catrinescu, Loïc Binan, Santiago Costantino, & Leonard A. Levin. (2017). Axonal Degeneration in Retinal Ganglion Cells Is Associated with a Membrane Polarity-Sensitive Redox Process. Journal of Neuroscience. 37(14). 3824–3839. 29 indexed citations
15.
Niemuth, Nicholas J., et al.. (2016). Intracellular disulfide reduction by phosphine-borane complexes: Mechanism of action for neuroprotection. Neurochemistry International. 99. 24–32. 12 indexed citations
16.
Levin, Leonard A., Harry A. Quigley, M. Francesca Cordeiro, et al.. (2016). Neuroprotection for glaucoma: Requirements for clinical translation. Experimental Eye Research. 157. 34–37. 47 indexed citations
17.
Catrinescu, Maria‐Magdalena, et al.. (2010). Iron and Manganese Corroles Are Neuroprotective for Serum-Deprived Retinal Neurons. Investigative Ophthalmology & Visual Science. 51(13). 3712–3712. 1 indexed citations
18.
Levin, Leonard A., et al.. (2009). Identification of Protein Targets of Novel Neuroprotective Sulfhydryl Reducing Drugs. Investigative Ophthalmology & Visual Science. 50(13). 3190–3190. 1 indexed citations
19.
Nork, T. Michael, et al.. (2005). Multifocal Electroretinographic (mfERG) Evidence for Persistent Outer Retinal Injury in Chronic Ocular Hypertension in Non–Human Primates. Investigative Ophthalmology & Visual Science. 46(13). 4663–4663. 1 indexed citations
20.
Schwartz, Michal, et al.. (1999). ‘Axogenic’ and ‘somagenic’ neurodegenerative diseases: definitions and therapeutic implications. Molecular Medicine Today. 5(11). 470–473. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026